Zydus Cadila Current Affairs, GK & News

DCGI approves ZyCoV-D vaccine for Emergency Use Authorization

The Drug Controller General of India (DGCI) has approved ZyCoV-D vaccine by Zydus Cadila for Emergency Use Authorization. Key Points According to Ministry of Science and Technology, ZyCoV-D vaccine is the world’s first and India’s indigenously developed DNA-based vaccine for COVID-19. It will be administered to humans including children and adults aged 12 years and ..

Month: 

Category: 

Topics: 

Zydus drug Virafin gets DCGI nod

The Drug Controller General of India recently provided “Restricted Emergency Use Approval” for the use of “Virafin”. Virafin is used to treat Hepatitis B and C. Now it is to be used to treat moderate COVID-19 infections. About Virafin A single dose of Virafin during the early stage of infection, will help COVID-19 patients recover ..

Month: 

Category: 

Topics: 

Zydus Cadila launched the cheapest generic version of Remdesivir in India

Zydus Cadila launched the cheapest generic version of Gilead Sciences’ antiviral drug Remdesivir in India to treat the deadly COVID 19 pandemic. The version has been launched after reports of a shortage of the drugs in the hospitals of the country. The price of drugs has been fixed as Rs 2800 per 100 mg vial. ..

Month: 

Category: 

Topics: 

Indian Company Zydus Cadila Starts Clinical Trial for COVID 19 Vaccine

The Indian pharmaceutical behemoth, Zydus Cadila, has started the Phase I, II clinical trials for its COVID 19 vaccine. The pharma giant had received approval from the Drug Controller General of India for clinical trials earlier this month. The company has started its trial with 1048 subjects by intradermal injection route. The Clinical Trial Registry ..

Month: 

Category: 

Topics: 

ICMR to launch COVAXIN on August 15

On July 2, 2020, Indian Council of Medical Research announced that it is to launch COVAXIN, India’s first COVID-19 vaccine by August 15. Highlights There are 12 institutes that are conducting the clinical trials of the indigenous vaccine. Currently India has two indigenous manufacturers that are approved to conduct clinical trials for COVID-19 vaccine. They ..

Month: 

Category: 

Topics: